Paul S Haber, MBBS
Sydney Local Health District
3
3
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Fiellin, MD
Yale University
Shared therapeutic areas:
Kirsten C Morley, PhD
University of Sydney
Shared therapeutic areas:
Worked with same sponsors:
Andrew Baillie, PhD
Macquarie University
Shared therapeutic areas:
Worked with same sponsors:
Vijay A Ramchandani, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Shared therapeutic areas:
Niklaus D Labhardt, MD, MIH
Swiss Tropical & Public Health Institute
Shared therapeutic areas:
David Spiegel, M.D.
Stanford University
Shared therapeutic areas:
Elizabeth Ralevski, Ph.D.
Yale University
Shared therapeutic areas:
Eric Nguyen-Khac, MD, PhD
CHU Amiens
Shared therapeutic areas:
Sabine Vollstädt-Klein, Prof. Dr.
Central Institute of Mental Health, Mannheim
Shared therapeutic areas:
Bernard Le Foll, MD, PhD
Centre for Addiction and Mental Health
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence
Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
All 3 trials loaded